Cite
HARVARD Citation
Eliades, P. et al. (2016). A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors. Cancer biology & therapy. 17 (7), pp. 778-784. [Online].